RCAN1 Antikörper (AA 1-100)
-
- Target Alle RCAN1 Antikörper anzeigen
- RCAN1 (Regulator of Calcineurin 1 (RCAN1))
-
Bindungsspezifität
- AA 1-100
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser RCAN1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunofluorescence (IF)
- Verwendungszweck
- Mouse monoclonal antibody raised against a partial recombinant DSCR1.
- Sequenz
- MEEVDLQDLP SATIACHLDP RVFVDGLCRA KFESLFRTYD KDITFQYFKS FKRVRINFSN PFSAADARLQ LHKTEFLGKE MKLYFAQTLH IGSSHLAPPN
- Kreuzreaktivität
- Human
- Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
- Immunogen
- DSCR1 (AAH02864, 1 a.a. ~ 100 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
- Klon
- 1B1
- Isotyp
- IgG2b
- Top Product
- Discover our top product RCAN1 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- In 1x PBS, pH 7.4
- Handhabung
- Aliquot to avoid repeated freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
Creation and characterization of BAC-transgenic mice with physiological overexpression of epitope-tagged RCAN1 (DSCR1)." in: Mammalian genome : official journal of the International Mammalian Genome Society, Vol. 24, Issue 1-2, pp. 30-43, (2013) (PubMed).
: "
-
Creation and characterization of BAC-transgenic mice with physiological overexpression of epitope-tagged RCAN1 (DSCR1)." in: Mammalian genome : official journal of the International Mammalian Genome Society, Vol. 24, Issue 1-2, pp. 30-43, (2013) (PubMed).
-
- Target
- RCAN1 (Regulator of Calcineurin 1 (RCAN1))
- Andere Bezeichnung
- RCAN1 (RCAN1 Produkte)
- Hintergrund
-
Full Gene Name: regulator of calcineurin 1
Synonyms: ADAPT78,CSP1,DSC1,DSCR1,MCIP1,RCN1 - Gen-ID
- 1827
- Pathways
- Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development
-